{"schema_version":"secwatch.filing_event.v1","accession":"0000310764-25-000005","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2025-01-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.930984+00:00","generated_at":"2026-05-27T08:37:32.116402+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Stryker Q4 adjusted EPS up 15.9% to $4.01, organic sales +10.2%; guides 2025 8-9% growth","bullets":["Reported EPS fell 52.7% to $1.41 due to $818M goodwill/impairment charges on Spine; adjusted EPS rose 15.9% to $4.01.","Organic net sales increased 10.2% in Q4 and full year 2024, driven by 9.1% volume growth and 1.1% price.","Full-year adjusted operating margin expanded 110 bps to 25.3%; reported operating margin was 16.3%.","2025 guidance: organic sales growth 8-9%, adjusted EPS $13.45-$13.70; Inari acquisition expected to close late Feb with ~$590M stub sales."],"urls":{"canonical":"https://secwatch.observer/filing/0000310764-25-000005","json":"https://secwatch.observer/filing/0000310764-25-000005.json","markdown":"https://secwatch.observer/filing/0000310764-25-000005.md","text":"https://secwatch.observer/filing/0000310764-25-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000005/0000310764-25-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000005/syk-20250128.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T08:37:32.116402+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}